Blake Schroeder is listed as a director on 3 SEC Form D filings by 2 issuers between May 2018 and Feb 2021: NEUROPATHIX, INC. (Doylestown, PA — biotechnology — 2020–2021; $1.21M reported sold to 1 investors) and AXIM BIOTECHNOLOGIES, INC. (San Diego, CA — biotechnology — 2018; $600K reported sold to 1 investors).
What this means 2 separate companies raised money with this person listed as director, over about 3 years. Across those companies the filings report $1.81M sold in total.
Listed alongside ROBERT MALASEK (3 shared filings), Thomas Kikis (2 shared filings), Timothy Scott (2 shared filings), William Kinney (2 shared filings), Dead Petkanas (1 shared filing) and 7 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Blake. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 3 public filings for Blake Schroeder and found 4 differences: No amendment in the last 12 months on an offering that may still be open; Blake Schroeder is written 2 different ways on the filings; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.